Table 1 Baseline characteristics of the study patients
From: Acute retinal necrosis. Management and visual outcomes: a case series
Mean Age (Years) ± Standard Deviation | 50.57 ± 13.658 |
Gender N (%) | |
Male | 16 (69.6%) |
Female | 7 (30.4%) |
Laterality N (%) | |
Right Eye | 18 (78.3%) |
Left Eye | 5 (21.7%) |
Baseline Visual Acuity In LogMA (Mean ± SD) | 1.34 ± 0.95 |
Mean follow-up duration, month (Range) | 11 (6–41) |
Extent of retinitis N (%) | |
1 Quadrant | 0 |
2 Quadrants | 9 (39.1%) |
3 Quadrants | 8 (34.8%) |
4 Quadrants | 6 (26.1%) |
Type of anterior chamber reaction N (%) | |
Granulomatous | 12 (52.2%) |
Non-Granulomatous | 11 (47.8%) |
PCR Result N (%) | |
Varicella Zoster Virus | 16 (69.6%) |
Cytomegalovirus | 3 (13.0%) |
Herpes Simplex Virus (HSV) | 1 (4.3%) |
Negative | 1 (4.3%) |
No Data | 2 (8.7%) |
Treatment modality | |
Intravenous acyclovir, N (%) | 20 (86.9%) |
Oral acyclovir, N (%) | 4 (17.4%) |
Oral valacyclovir, N (%) | 14 (61%) |
Oral valganciclovir, N (%) | 3 (13%) |
Intravitreal ganciclovir, N (%) | 23 (100%) |
Laser Retinopexy, N (%) | 15 (65.2%) |